Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.
Dendritic Cells From the Cervical Mucosa Capture and Transfer HIV-1 via Siglec-1.
Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry.
P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.
Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation.
Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions.
Identification of Siglec-1 null individuals infected with HIV-1.
HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression.